THE Pharmacy Programs Administrator is working with the Department of Health to support registration for all pharmacies to participate in the National Take Home Naloxone Program, which will be implemented in all Australian states and territories from 01 Jul 2022.
The 2022-23 Federal Budget saw the Government commit $19.6 million over four years to the program, which will see Naloxone available nationally at no cost and without a prescription to anyone who may experience, or witness, an opioid overdose or adverse reaction.
The rollout follows the evidence-based evaluation of the Take Home Naloxone trial which ran though to 30 Jun last year (PD 26 Nov 2019).
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Apr 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Apr 22
